Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: GlobalData | PRODUCT CODE: 1617473

Cover Image

PUBLISHER: GlobalData | PRODUCT CODE: 1617473

United States Syringes, Needles and Urinary Catheters Market Outlook to 2033 - Needles, Syringes and Urinary Catheters

PUBLISHED:
PAGES: 40 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4995
PDF (Site License)
USD 9990
PDF (Global License)
USD 14985

Add to Cart

GlobalData's "United States Syringes, Needles and Urinary Catheters Outlook to 2033" is a comprehensive databook report, covering key market data on the United States Syringes, Needles and Urinary Catheters market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Syringes, Urinary Catheters and Needles

The United States Syringes, Needles and Urinary Catheters Market report provides key information and data on -

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share and distribution share data for Syringes, Needles and Urinary Catheters Market.
  • Global corporate-level profiles of key companies operating within the United States Syringes, Needles and Urinary Catheters Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Syringes, Needles and Urinary Catheters is segmented as follows -

  • Syringes
  • Urinary Catheters
  • Needles

Reasons to Buy

The United States Syringes, Needles and Urinary Catheters Market report helps you to develop -

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Product Code: GDME1056CCDB

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 What Is This Report About?
  • 2.2 Syringes, Needles and Urinary Catheters Market Segmentation
  • 2.3 Definitions of Markets Covered in the Report

3 Syringes, Needles and Urinary Catheters Market, United States

  • 3.1 Syringes, Needles and Urinary Catheters Market, United States, Revenue ($m), 2018-2033
    • 3.1.1 Urinary Catheters Market, United States, Revenue ($m), by Segment, 2018-2033
  • 3.2 Syringes, Needles and Urinary Catheters Market, United States, Volume (Units), 2018-2033
    • 3.2.1 Urinary Catheters Market, United States, Volume (Units), by Segment, 2018-2033
  • 3.3 Syringes, Needles and Urinary Catheters Market, United States, Average Price ($), 2018-2033
  • 3.4 Syringes, Needles and Urinary Catheters Market, United States, Distribution Share by Revenue ($m), 2023
  • 3.5 Syringes, Needles and Urinary Catheters Market, United States, Company Share by Revenue ($m), 2023

4 Overview of Key Companies in United States, Syringes, Needles and Urinary Catheters Market

  • 4.1 Becton Dickinson and Co
    • 4.1.1 Company Overview
  • 4.2 Cardinal Health Inc
    • 4.2.1 Company Overview
  • 4.3 Stryker Corp
    • 4.3.1 Company Overview
  • 4.4 Medline Industries LP
    • 4.4.1 Company Overview
  • 4.5 Avanos Medical Inc
    • 4.5.1 Company Overview

5 Syringes, Needles and Urinary Catheters Market Pipeline Products

6 Financial Deals Landscape

  • 6.1 Asset Transactions
    • 6.1.1 Sharps Technology to Acquire InjectEZ Specialty Syringe Manufacturing Assets from Nephron Pharma for USD35 Million
  • 6.2 Debt Offerings
    • 6.2.1 Zimmer Biomet Holdings Prices USD743.76 Million in Public Offering of 3.518% Notes Due 2032

7 Recent Developments

  • 7.1 Corporate Communications
    • 7.1.1 Oct 02, 2024: PharmaJet Names Wouter Latour as Chief Executive Officer
    • 7.1.2 Feb 28, 2024: Bob Azelby to Join Cardinal Health Board of Directors
  • 7.2 Financial Announcements
    • 7.2.1 Nov 01, 2024: Cardinal Health Announces Q1 Fiscal Year 2025 Results
    • 7.2.2 Oct 10, 2024: BD to Announce its Fiscal 2024 Fourth Quarter and Full Year Financial Results
    • 7.2.3 Oct 09, 2024: Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2024 Financial Results
    • 7.2.4 Oct 08, 2024: Merit Medical Systems to Announce Third Quarter 2024 Results on October 30, 2024
    • 7.2.5 Aug 14, 2024: Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance
    • 7.2.6 Aug 07, 2024: Zimmer Biomet Announces Second Quarter 2024 Financial Results
    • 7.2.7 Aug 01, 2024: Merit Medical Systems Announces Q2 2024 Results and Raises Full-Year Guidance
    • 7.2.8 Aug 01, 2024: Axonics Reports Second Quarter 2024 Financial Results
    • 7.2.9 Jul 03, 2024: BD to Announce Financial Results for its Third Quarter of Fiscal 2024
    • 7.2.10 Jun 18, 2024: Merit Medical Systems to Announce Second Quarter 2024 Results on August 1, 2024
  • 7.3 Government and Public Interest
    • 7.3.1 Dec 01, 2023: Retractable Technologies Not Impacted by FDA Safety Communication
    • 7.3.2 Dec 01, 2023: Sol-Millennium Responds to FDA Safety Communication
  • 7.4 Legal And Regulatory
    • 7.4.1 Apr 24, 2024: WARNING LETTER : Cardinal Health 200 LLC
    • 7.4.2 Mar 21, 2024: Sol-Millennium Responds to FDA's Warning Letter and Safety Communication

8 Appendix

  • 8.1 Research Methodology
    • 8.1.1 Coverage
    • 8.1.2 Secondary Research
    • 8.1.3 Primary Research
    • 8.1.4 Market Modeling and Forecasting
    • 8.1.5 Company Share Analysis
    • 8.1.6 Distribution Share Analysis
    • 8.1.7 Benchmarking
  • 8.2 GlobalData Consulting
  • 8.3 Contact Us
  • 8.4 Disclaimer
Product Code: GDME1056CCDB

List of Tables

  • Table 1: Syringes, Needles and Urinary Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 2: Urinary Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Table 3: Syringes, Needles and Urinary Catheters Market, United States, Volume (Units), 2018-2033
  • Table 4: Urinary Catheters Market, United States, Volume (Units), 2018-2033
  • Table 5: Syringes, Needles and Urinary Catheters Market, United States, Average Price ($), 2018-2033
  • Table 6: Syringes, Needles and Urinary Catheters Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
  • Table 7: Syringes, Needles and Urinary Catheters Market, United States, Company Share by Revenue ($m), USD Constant, 2023
  • Table 8: Syringes, Needles and Urinary Catheters Market Pipeline Products
  • Table 9: Sharps Technology to Acquire InjectEZ Specialty Syringe Manufacturing Assets from Nephron Pharma for USD35 Million
  • Table 10: Zimmer Biomet Holdings Prices USD743.76 Million in Public Offering of 3.518% Notes Due 2032
  • Table 11: Total Number of Primary Research Participants, Hospital Supplies Market, by Country

List of Figures

  • Figure 1: Syringes, Needles and Urinary Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 2: Urinary Catheters Market, United States, Revenue ($m), USD Constant, 2018-2033
  • Figure 3: Syringes, Needles and Urinary Catheters Market, United States, Volume (Units), 2018-2033
  • Figure 4: Urinary Catheters Market, United States, Volume (Units), 2018-2033
  • Figure 5: Syringes, Needles and Urinary Catheters Market, United States, Company Share (%) 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!